Available Strain Details

Strain Information
Common Strain Name: MH19 Pricing and Ordering Information
Strain Nomenclature: FVB/N-Tg(MT-HGFSF)19Lmb/Nci
Animal State: Cryoarchived Strains
Release Category (Required for MTA form): C1,D


Strain Description: MH19 is a transgenic line that overexpresses mouse Scatter factor/hepatocyte growth factor under control of the mouse metallothionein I promoter. Expression can be detected in virtually all adult tissues, at a level between 3- and 50-fold higher than the endogenous gene, Hgf (Takayama et al., 1996). Over half of the female transgenic mice die by 6 months of age of intestinal obstruction or renal failure. Hind limb paralysis due to ectopic development of striated muscle in the central nervous system was observed in 5% of the animals at 4.5-6.5 weeks of age (Takayama et al., 1996). MH19 mice developed multiple tumors at 2.5-20 months of age (Takayama et al., 1997). Lesions were of epithelial and mesenchymal origin. They included skin fibrosarcomas, hepatocellular adenomas, hemangiosarcomas, rhabdomyosarcomas, mammary tumors (Takayama et al., 1997), and malignant melanoma (Otsuka et al., 1998). MH19 mice tend to develop a rectal prolapse, which occasionally can be severe.
Mutation Information
Mutation Type: Transgenic
Gene Name:
Gene Symbol:
Transgene Name: Scatter factor/hepatocyte growth factor
Transgene Symbol: SCATTER
Promotor Name: metallothionein (mouse)
Promotor Symbol: mMT-1
Current Genetic Background: FVB/N
Approx. Generation: 8
Organ Site:
Additional Information
Cryopreservation Mating Scheme: The cryopreservation mating scheme is FVB females x hemizygous males. When maintained as a live colony, breeder pairs were distributed as a hemizygote male x wildtype FVB female. Female transgenics can experience abnormal development of reproductive organs, so breeding should routinely be between transgenic males and FVB females. Unfortunately, there are a number of males that never breed. Average litter size is 7.
Genotyping Information: Protocol 1: Allele: Tg(MT-HGFSF)19Lmb
Donating Investigator: Dr. Glenn Merlino

Key Reference: Takayama H, LaRochelle WJ, Anver M, Bockman DE, Merlino G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci USA 93, 5866-5871, 1996. PMID:8650184 [Pubmed Abstract]

Related Reference: Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94, 701-706, 1997. PMID:9012848 [Pubmed Abstract]

Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G. C-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 58, 5157-5167. PMID: 9823327 [Pubmed Abstract]

Sponsor: NCI/CCR Research Funds